113 related articles for article (PubMed ID: 17417078)
1. 13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot study.
de Wildt SN; Berns MJ; van den Anker JN
Ther Drug Monit; 2007 Apr; 29(2):225-30. PubMed ID: 17417078
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Pai AB; Norenberg J; Boyd A; Raj D; Chan LN
Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586
[TBL] [Abstract][Full Text] [Related]
3. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
[TBL] [Abstract][Full Text] [Related]
4. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Kurnik D; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin.
Paine MF; Wagner DA; Hoffmaster KA; Watkins PB
Clin Pharmacol Ther; 2002 Nov; 72(5):524-35. PubMed ID: 12426516
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
Stein CM; Kinirons MT; Pincus T; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1996 Jan; 59(1):47-51. PubMed ID: 8549033
[TBL] [Abstract][Full Text] [Related]
7. The erythromycin breath test predicts the clearance of midazolam.
Lown KS; Thummel KE; Benedict PE; Shen DD; Turgeon DK; Berent S; Watkins PB
Clin Pharmacol Ther; 1995 Jan; 57(1):16-24. PubMed ID: 7828377
[TBL] [Abstract][Full Text] [Related]
8. Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans.
Okudaira T; Kotegawa T; Imai H; Tsutsumi K; Nakano S; Ohashi K
J Clin Pharmacol; 2007 Jul; 47(7):871-6. PubMed ID: 17585116
[TBL] [Abstract][Full Text] [Related]
9. Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test.
Pons G; Blais JC; Rey E; Plissonnier M; Richard MO; Carrier O; d'Athis P; Moran C; Badoual J; Olive G
Pediatr Res; 1988 Jun; 23(6):632-6. PubMed ID: 3134644
[TBL] [Abstract][Full Text] [Related]
10. The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats.
Sugiyama E; Kikuchi A; Inada M; Sato H
J Pharm Sci; 2011 Sep; 100(9):3995-4005. PubMed ID: 21618542
[TBL] [Abstract][Full Text] [Related]
11. Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.
Lemahieu WP; Maes BD; Ghoos Y; Rutgeerts P; Verbeke K; Vanrenterghem Y
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G470-82. PubMed ID: 12909563
[TBL] [Abstract][Full Text] [Related]
12. Use of a breath test to determine the fate of swallowed fluids in cattle.
McLeay LM; Carruthers VR; Neil PG
Am J Vet Res; 1997 Nov; 58(11):1314-9. PubMed ID: 9361898
[TBL] [Abstract][Full Text] [Related]
13. Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin.
Elens L; Nieuweboer AJ; Clarke SJ; Charles KA; de Graan AJ; Haufroid V; van Gelder T; Mathijssen RH; van Schaik RH
Pharmacogenet Genomics; 2013 Mar; 23(3):148-55. PubMed ID: 23324807
[TBL] [Abstract][Full Text] [Related]
14. The erythromycin breath test for the prediction of drug clearance.
Rivory LP; Slaviero KA; Hoskins JM; Clarke SJ
Clin Pharmacokinet; 2001; 40(3):151-8. PubMed ID: 11327195
[TBL] [Abstract][Full Text] [Related]
15. Measurement of hepatic phenylalanine metabolism in children using the [(13)C]-phenylalanine breath test and gas chromatography-mass spectrometry.
Wada M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 806(1):5-10. PubMed ID: 15149604
[TBL] [Abstract][Full Text] [Related]
16. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ketoconazole on the activity of CYP4503A4 and CYP450 1A2 of hepatic microsomes in healthy adults].
Yang GZ; Yuan Y; Zhou QX; Yang JQ; Liu YJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1634-5, 1639. PubMed ID: 18819885
[TBL] [Abstract][Full Text] [Related]
18. Single breath CO measurements normalized to 5% CO2 in Coombs' test positive neonates.
Engel RR; Popelka G
Physiol Meas; 2007 Sep; 28(9):977-88. PubMed ID: 17827647
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test.
Michael M; Cullinane C; Hatzimihalis A; O'Kane C; Milner A; Booth R; Schlicht S; Clarke SJ; Francis P
Cancer Chemother Pharmacol; 2012 Jan; 69(1):125-35. PubMed ID: 21626050
[TBL] [Abstract][Full Text] [Related]
20. Results of L-[1-13C]phenylalanine breath test with air isotope ratio mass spectrometry can reflect the activity of phenylalanine hydroxylase in cirrhotic rat liver.
Yan W; Xiong P; Liu Z; Huang G
Rapid Commun Mass Spectrom; 2006; 20(4):602-8. PubMed ID: 16429477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
